Etto C. Eringa
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial.
Journal: Journal of the American College of Cardiology
Published: July 21, 2026
Rationale and design of the vericiguat in vasospastic angina (ViVA) trial: A double-blind placebo-controlled randomized cross-over study.
Journal: American heart journal
Published: December 04, 2025
Plasma Metabolite N-Formylmethionine Is Associated With Higher Blood Pressure in the Multiethnic HELIUS Cohort and Triggers Vascular Dysfunction.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: September 17, 2025
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trial.
Journal: European journal of heart failure
Published: August 12, 2025
Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation.
Journal: Cardiovascular diabetology
Published: July 10, 2025
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: April 25, 2025
Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial.
Journal: European journal of heart failure
Published: April 12, 2025
Geranylgeranylacetone as Prevention for Postoperative Atrial Fibrillation (GENIALITY).
Journal: Cardiovascular drugs and therapy
Published: March 22, 2025
Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failure.
Journal: European journal of heart failure
Published: January 13, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Journal: Cardiovascular diabetology
Published: December 10, 2024
Relationship between peripheral and intracoronary blood flow in patients with angina and nonobstructive coronary arteries.
Journal: American journal of physiology. Heart and circulatory physiology
Published: August 30, 2024
Last Updated: 09/26/2026